Skip to Main Content

Advertisement

Skip Nav Destination

First Edition

Research Article July 21 2021
Prognostic value of minimal residual disease negativity in myeloma: combined analysis of POLLUX, CASTOR, ALCYONE, MAIA
Brief Report July 21 2021
Phase I study of Ibrutinib and the CXCR4 antagonist Ulocuplumab in CXCR4 mutated Waldenstrom Macroglobulinemia
Research Article July 20 2021
Unexpected suppression of tumorigenesis by c-MYC via TFAP4-dependent restriction of stemness in B lymphocytes
Research Article July 19 2021
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC specific T-cell bispecific antibody
Research Article July 19 2021
BTK inhibition sensitizes Acute Lymphoblastic Leukemia to asparaginase by suppressing the Amino Acid Response pathway
Research Article July 19 2021
Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein
Research Article July 16 2021
Sustained Minimal Residual Disease Negativity With Daratumumab in Newly Diagnosed Multiple Myeloma: MAIA and ALCYONE
Research Article July 16 2021
Genetic Variants Associated with Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation
Research Article July 15 2021
CD63 is Regulated by Iron via the IRE-IRP System and is Important for Ferritin Secretion by Extracellular Vesicles
Research Article July 15 2021
Belumosudil for Chronic Graft-versus-Host Disease (cGVHD) After 2 or More Prior Lines of Therapy: The ROCKstar Study
Discussion July 14 2021
Is it time for PET-guided therapy in follicular lymphoma.
Research Article July 13 2021
A Critical Role of Nuclear m6A Reader YTHDC1 in Leukemogenesis by Regulating MCM Complex-Mediated DNA Replication
Research Article July 13 2021
DYRK1a mediates BAFF-induced noncanonical NF-kB activation to promote autoimmunity and B cell leukemogenesis
Research Article July 7 2021
Multimodal single-cell analysis of cutaneous T cell lymphoma reveals distinct sub-clonal tissue-dependent signatures.
Research Article July 7 2021
The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
Brief Report July 7 2021
JAK inhibition for murine HLH requires complete blockade of IFNg signaling and is limited by toxicity of JAK2 inhibition
Research Article July 7 2021
CYB561A3 is the Key Lysosomal Iron Reductase Required for Burkitt B-cell Growth and Survival
Letter July 7 2021
Menin inhibition decreases Bcl-2 and synergizes with venetoclax in NPM1/FLT3-mutated AML
Research Article July 1 2021
Treatment of sickle cell disease by increasing oxygen affinity of hemoglobin
Review Article June 30 2021
Remission, treatment failure, and relapse in pediatric ALL: An international consensus of the Ponte-di-Legno Consortium
Research Article June 29 2021
SOX11, CD70 and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma
Research Article June 29 2021
Complement mediates binding and procoagulant effects of ultra-large HIT immune complexes
Research Article June 29 2021
The Protein Landscape of Chronic Lymphocytic Leukemia (CLL)
Research Article June 29 2021
Functional characterization of 105 Factor H variants associated with atypical HUS: lessons for variant classification.
Research Article June 24 2021
Immune control of cytomegalovirus reactivation in stem cell transplantation
Research Article June 24 2021
CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma
Research Article June 24 2021
Incidence and Prognosis of Clonal Hematopoiesis in patients with Chronic Idiopathic Neutropenia
Research Article June 24 2021
Type I interferon is induced by hemolysis and drives antibody-mediated erythrophagocytosis in sickle cell disease
Research Article June 23 2021
Combined effects of plasma von Willebrand factor and platelet measures on the risk of incident venous thromboembolism
Research Article June 22 2021
Omidubicel Versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized Study
Brief Report June 17 2021
CHIP & HIPs: Clonal Hematopoiesis is Common in Hip Arthroplasty Patients and Associates with Autoimmune Disease
Research Article June 16 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88 driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance.
Research Article June 16 2021
Transcriptomic Landscape of Circulating Mononuclear Phagocytes in Langerhans Cell Histiocytosis at Single-cell Level
Brief Report June 16 2021
Tumor cells in light-chain amyloidosis and myeloma show different transcriptional rewiring of normal plasma cell development
Research Article June 14 2021
PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL
Research Article June 14 2021
Tumor suppressor function of Gata2 in Acute Promyelocytic Leukemia
Letter June 14 2021
Immune evasion in primary testicular and central nervous system lymphomas: HLA I and II loss rather than 9p24.1/PD-L1/PD-L2 alterations
Research Article June 14 2021
Clinical relevance of clonal hematopoiesis in the oldest-old population
Research Article June 11 2021
Dual role of EZH2 on megakaryocyte differentiation
Research Article June 11 2021
Integrated Genomic Analyses of Cutaneous T Cell Lymphomas Reveal the Molecular Bases for Disease Heterogeneity
Research Article June 11 2021
Single-Cell Analysis of Ploidy and Transcriptome Reveals Functional and Spatial Divergency in Murine Megakaryopoiesis
Research Article June 11 2021
Heterozygous Variants of CLPB are a Cause of Severe Congenital Neutropenia
Research Article June 11 2021
Somatic uniparental disomy mitigates the most damaging EFL1 allele combination in Shwachman-Diamond syndrome
Research Article June 11 2021
How I treat pediatric acute myeloid leukemia
Brief Report June 11 2021
Cereblon Enhancer Methylation and IMiD Resistance in Multiple Myeloma
Research Article June 10 2021
Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia
Research Article June 10 2021
MiR-130b and miR-128a are essential lineage-specific co-drivers of t(4;11) MLL-AF4 acute leukemia
Discussion June 10 2021
Distinguishing AML from MDS: A fixed blast percentage may no longer be optimal
Research Article June 10 2021
Depalmitoylation Rewires FLT3-ITD Signaling and Exacerbates Leukemia Progression
Research Article June 7 2021
MicroRNA-497/195 is tumor-suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia
Page 3 of 4
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X